243 related articles for article (PubMed ID: 17822893)
1. (3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
Wright SW; Ammirati MJ; Andrews KM; Brodeur AM; Danley DE; Doran SD; Lillquist JS; Liu S; McClure LD; McPherson RK; Olson TV; Orena SJ; Parker JC; Rocke BN; Soeller WC; Soglia CB; Treadway JL; Vanvolkenburg MA; Zhao Z; Cox ED
Bioorg Med Chem Lett; 2007 Oct; 17(20):5638-42. PubMed ID: 17822893
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K
Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000
[TBL] [Abstract][Full Text] [Related]
3. From lead to preclinical candidate: optimization of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IV.
Nordhoff S; López-Canet M; Hoffmann-Enger B; Bulat S; Cerezo-Gálvez S; Hill O; Rosenbaum C; Rummey C; Thiemann M; Matassa VG; Edwards PJ; Feurer A
Bioorg Med Chem Lett; 2009 Aug; 19(16):4818-23. PubMed ID: 19576767
[TBL] [Abstract][Full Text] [Related]
4. Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors.
Pei Z; Li X; Longenecker K; von Geldern TW; Wiedeman PE; Lubben TH; Zinker BA; Stewart K; Ballaron SJ; Stashko MA; Mika AK; Beno DW; Long M; Wells H; Kempf-Grote AJ; Madar DJ; McDermott TS; Bhagavatula L; Fickes MG; Pireh D; Solomon LR; Lake MR; Edalji R; Fry EH; Sham HL; Trevillyan JM
J Med Chem; 2006 Jun; 49(12):3520-35. PubMed ID: 16759095
[TBL] [Abstract][Full Text] [Related]
5. cis-2,5-dicyanopyrrolidine inhibitors of dipeptidyl peptidase IV: synthesis and in vitro, in vivo, and X-ray crystallographic characterization.
Wright SW; Ammirati MJ; Andrews KM; Brodeur AM; Danley DE; Doran SD; Lillquist JS; McClure LD; McPherson RK; Orena SJ; Parker JC; Polivkova J; Qiu X; Soeller WC; Soglia CB; Treadway JL; VanVolkenburg MA; Wang H; Wilder DC; Olson TV
J Med Chem; 2006 Jun; 49(11):3068-76. PubMed ID: 16722626
[TBL] [Abstract][Full Text] [Related]
6. Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors.
Ashton WT; Dong H; Sisco RM; Doss GA; Leiting B; Patel RA; Wu JK; Marsilio F; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2004 Feb; 14(4):859-63. PubMed ID: 15012982
[TBL] [Abstract][Full Text] [Related]
7. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT
Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors.
Kowalchick JE; Leiting B; Pryor KD; Marsilio F; Wu JK; He H; Lyons KA; Eiermann GJ; Petrov A; Scapin G; Patel RA; Thornberry NA; Weber AE; Kim D
Bioorg Med Chem Lett; 2007 Nov; 17(21):5934-9. PubMed ID: 17827003
[TBL] [Abstract][Full Text] [Related]
9. (3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Biftu T; Feng D; Qian X; Liang GB; Kieczykowski G; Eiermann G; He H; Leiting B; Lyons K; Petrov A; Sinha-Roy R; Zhang B; Scapin G; Patel S; Gao YD; Singh S; Wu J; Zhang X; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2007 Jan; 17(1):49-52. PubMed ID: 17055272
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration.
Kondo T; Nekado T; Sugimoto I; Ochi K; Takai S; Kinoshita A; Tajima Y; Yamamoto S; Kawabata K; Nakai H; Toda M
Bioorg Med Chem; 2007 Apr; 15(7):2631-50. PubMed ID: 17293118
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors: oxadiazolyl ketones.
Koo KD; Kim MJ; Kim S; Kim KH; Hong SY; Hur GC; Yim HJ; Kim GT; Han HO; Kwon OH; Kwon TS; Koh JS; Lee CS
Bioorg Med Chem Lett; 2007 Aug; 17(15):4167-72. PubMed ID: 17544668
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors.
Corbett JW; Dirico K; Song W; Boscoe BP; Doran SD; Boyer D; Qiu X; Ammirati M; Vanvolkenburg MA; McPherson RK; Parker JC; Cox ED
Bioorg Med Chem Lett; 2007 Dec; 17(24):6707-13. PubMed ID: 17977724
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279): a very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes.
Madar DJ; Kopecka H; Pireh D; Yong H; Pei Z; Li X; Wiedeman PE; Djuric SW; Von Geldern TW; Fickes MG; Bhagavatula L; McDermott T; Wittenberger S; Richards SJ; Longenecker KL; Stewart KD; Lubben TH; Ballaron SJ; Stashko MA; Long MA; Wells H; Zinker BA; Mika AK; Beno DW; Kempf-Grote AJ; Polakowski J; Segreti J; Reinhart GA; Fryer RM; Sham HL; Trevillyan JM
J Med Chem; 2006 Oct; 49(21):6416-20. PubMed ID: 17034148
[TBL] [Abstract][Full Text] [Related]
14. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
[TBL] [Abstract][Full Text] [Related]
15. 2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV.
Haffner CD; McDougald DL; Reister SM; Thompson BD; Conlee C; Fang J; Bass J; Lenhard JM; Croom D; Secosky-Chang MB; Tomaszek T; McConn D; Wells-Knecht K; Johnson PR
Bioorg Med Chem Lett; 2005 Dec; 15(23):5257-61. PubMed ID: 16168640
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit.
Backes BJ; Longenecker K; Hamilton GL; Stewart K; Lai C; Kopecka H; von Geldern TW; Madar DJ; Pei Z; Lubben TH; Zinker BA; Tian Z; Ballaron SJ; Stashko MA; Mika AK; Beno DW; Kempf-Grote AJ; Black-Schaefer C; Sham HL; Trevillyan JM
Bioorg Med Chem Lett; 2007 Apr; 17(7):2005-12. PubMed ID: 17276063
[TBL] [Abstract][Full Text] [Related]
17. Discovery of non-covalent dipeptidyl peptidase IV inhibitors which induce a conformational change in the active site.
Sheehan SM; Mest HJ; Watson BM; Klimkowski VJ; Timm DE; Cauvin A; Parsons SH; Shi Q; Canada EJ; Wiley MR; Ruehter G; Evers B; Petersen S; Blaszczak LC; Pulley SR; Margolis BJ; Wishart GN; Renson B; Hankotius D; Mohr M; Zechel JC; Michael Kalbfleisch J; Dingess-Hammond EA; Boelke A; Weichert AG
Bioorg Med Chem Lett; 2007 Mar; 17(6):1765-8. PubMed ID: 17239592
[TBL] [Abstract][Full Text] [Related]
18. Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors.
Kurukulasuriya R; Rohde JJ; Szczepankiewicz BG; Basha F; Lai C; Jae HS; Winn M; Stewart KD; Longenecker KL; Lubben TW; Ballaron SJ; Sham HL; von Geldern TW
Bioorg Med Chem Lett; 2006 Dec; 16(24):6226-30. PubMed ID: 17010607
[TBL] [Abstract][Full Text] [Related]
19. Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors.
Caldwell CG; Chen P; He J; Parmee ER; Leiting B; Marsilio F; Patel RA; Wu JK; Eiermann GJ; Petrov A; He H; Lyons KA; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2004 Mar; 14(5):1265-8. PubMed ID: 14980678
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors.
Xu J; Wei L; Mathvink RJ; Edmondson SD; Eiermann GJ; He H; Leone JF; Leiting B; Lyons KA; Marsilio F; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2006 Oct; 16(20):5373-7. PubMed ID: 16919457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
